| Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 Y Xiang, S Nambulli, Z Xiao, H Liu, Z Sang, WP Duprex, ... Science 370 (6523), 1479-1484, 2020 | 349 | 2020 |
| ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSB Y Teng, T Yadav, M Duan, J Tan, Y Xiang, B Gao, J Xu, Z Liang, Y Liu, ... Nature communications 9 (1), 4115, 2018 | 142 | 2018 |
| Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses S Nambulli, Y Xiang, NL Tilston-Lunel, LJ Rennick, Z Sang, WB Klimstra, ... Science advances 7 (22), eabh0319, 2021 | 125 | 2021 |
| First community-wide, comparative cross-linking mass spectrometry study C Iacobucci, C Piotrowski, R Aebersold, BC Amaral, P Andrews, K Bernfur, ... Analytical chemistry 91 (11), 6953-6961, 2019 | 125 | 2019 |
| Impact of New Variants on SAR-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions MH Cheng, JM Krieger, Y Xiang, B Kaynak, Y Shi, M Arditi, I Bahar Available at SSRN 3907841, 2021 | 99* | 2021 |
| Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes YS Dapeng Sun, Zhe Sang, Yong Joon Kim, Yufei Xiang, Tomer Cohen, Anna K ... Nature Communications 12, 2021 | 86 | 2021 |
| FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation H Yang, Y Wang, Y Xiang, T Yadav, J Ouyang, L Phoon, X Zhu, Y Shi, ... Proceedings of the National Academy of Sciences 119 (12), e2116251119, 2022 | 50 | 2022 |
| Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies Y Xiang, Z Sang, L Bitton, J Xu, Y Liu, D Schneidman-Duhovny, Y Shi Cell systems 12 (3), 220-234. e9, 2021 | 40 | 2021 |
| Llamanade: An open-source computational pipeline for robust nanobody humanization Z Sang, Y Xiang, I Bahar, Y Shi Structure 30 (3), 418-429. e3, 2022 | 22 | 2022 |
| Nanobodies: Robust miniprotein binders in biomedicine JYJ Kim, Z Sang, Y Xiang, Z Shen, Y Shi Advanced Drug Delivery Reviews 195, 114726, 2023 | 19 | 2023 |
| A resource of high-quality and versatile nanobodies for drug delivery Z Shen, Y Xiang, S Vergara, A Chen, Z Xiao, U Santiago, C Jin, Z Sang, ... IScience 24 (9), 2021 | 15 | 2021 |
| Superimmunity by pan-sarbecovirus nanobodies Y Xiang, W Huang, H Liu, Z Sang, S Nambulli, J Tubiana, KL Williams, ... Cell Reports 39 (13), 2022 | 13 | 2022 |
| Ubiquitination-mediated degradation of TRDMT1 regulates homologous recombination and therapeutic response X Zhu, X Wang, W Yan, H Yang, Y Xiang, F Lv, Y Shi, H Li, L Lan NAR cancer 3 (1), zcab010, 2021 | 11 | 2021 |
| Reduced B cell antigenicity of Omicron lowers host serologic response J Tubiana, Y Xiang, L Fan, HJ Wolfson, K Chen, D Schneidman-Duhovny, ... Cell reports 41 (3), 2022 | 10 | 2022 |
| Chemical cross-linking and mass spectrometric analysis of the endogenous yeast exosome complexes Y Xiang, Z Shen, Y Shi The Eukaryotic RNA Exosome: Methods and Protocols, 383-400, 2020 | 10 | 2020 |
| Spt6 directly interacts with Cdc73 and is required for Paf1 complex occupancy at active genes in Saccharomyces cerevisiae MA Ellison, S Namjilsuren, MK Shirra, MS Blacksmith, RA Schusteff, ... Nucleic Acids Research 51 (10), 4814-4830, 2023 | 5 | 2023 |
| ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSB. Nat Commun 9: 4115 Y Teng, T Yadav, M Duan, J Tan, Y Xiang, B Gao, J Xu, Z Liang, Y Liu, ... | 5 | 2018 |
| The magic of linking rings: discovery of a unique photoinduced fluorescent protein crosslink M Lu, D Toptygin, Y Xiang, Y Shi, CD Schwieters, EC Lipinski, J Ahn, ... Journal of the American Chemical Society 144 (24), 10809-10816, 2022 | 4 | 2022 |
| Super-immunity by broadly protective nanobodies to sarbecoviruses Y Xiang, W Huang, H Liu, Z Sang, S Nambulli, J Tubiana, KL Williams Jr, ... bioRxiv, 2021.12. 26.474192, 2021 | 4 | 2021 |
| Coronavirus nanobodies and methods for their use and identification IY SHI, Y Xiang US Patent App. 18/022,033, 2024 | | 2024 |
Yi ShiThe Icahn School of Medicine at Mount Sinai, University of PittsburghVerified email at mssm.edu
